4H,7H-[1,3]thiazolo[5,4-d]pyrimidin-7-one, 95%, 100mg

4-BROMO-N-BUTYLBENZENESULPHONAMIDE, 98.0%, 5g

TERT-BUTYL 3-HYDROXY-4-PHENYLPYRROLIDINE-1-CARBOXYLATE (RACEMIC), 95.0%, 250mg

2-(Propylthio)pyrimidine-4,6-diol, 95.0%, 50mg

(S)-6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-ol, 97%, 5g

7-Iodo-1,2,3,4-tetrahydroquinoline, 97%, 1g

(R)-1-(PYRIDIN-2-YL)ETHANAMINE HCL, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-1, 20 m, 0,10 mm, 0,40 µm, 1 Pezzo(i)

(S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea, 98.0%, 5mg

5-Bromo-2-fluorobenzaldehyde, 98.0%, 100g

Piperidin-2-ylmethyl-carbamic acid tert-butyl ester, 95.0%, 10g

2-tert-Butyl-5-methyl-1H-indole, 97.0%, 500mg

MOZAVAPTAN, 99%, 10mg